670 related articles for article (PubMed ID: 19091823)
1. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Moayyedi P; Ford AC; Talley NJ; Cremonini F; Foxx-Orenstein AE; Brandt LJ; Quigley EM
Gut; 2010 Mar; 59(3):325-32. PubMed ID: 19091823
[TBL] [Abstract][Full Text] [Related]
2. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
Niu HL; Xiao JY
Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
[TBL] [Abstract][Full Text] [Related]
5. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
[TBL] [Abstract][Full Text] [Related]
6. Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis.
Wang W; Wang F; Fan F; Sedas AC; Wang J
Int J Behav Med; 2017 Apr; 24(2):191-204. PubMed ID: 27646279
[TBL] [Abstract][Full Text] [Related]
7. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
Hu Y; Tao L; Lyu B
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
9. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
10. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
McKenzie YA; Thompson J; Gulia P; Lomer MC;
J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
[TBL] [Abstract][Full Text] [Related]
11. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.
Wen Y; Li J; Long Q; Yue CC; He B; Tang XG
Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture for treatment of irritable bowel syndrome.
Lim B; Manheimer E; Lao L; Ziea E; Wisniewski J; Liu J; Berman B
Cochrane Database Syst Rev; 2006 Oct; (4):CD005111. PubMed ID: 17054239
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.
Hoveyda N; Heneghan C; Mahtani KR; Perera R; Roberts N; Glasziou P
BMC Gastroenterol; 2009 Feb; 9():15. PubMed ID: 19220890
[TBL] [Abstract][Full Text] [Related]
18. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
Ford AC; Harris LA; Lacy BE; Quigley EMM; Moayyedi P
Aliment Pharmacol Ther; 2018 Nov; 48(10):1044-1060. PubMed ID: 30294792
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC
Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528
[TBL] [Abstract][Full Text] [Related]
20. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis.
Manheimer E; Wieland LS; Cheng K; Li SM; Shen X; Berman BM; Lao L
Am J Gastroenterol; 2012 Jun; 107(6):835-47; quiz 848. PubMed ID: 22488079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
